This live session provides a focused overview of the relationship between neurodiversity and substance use disorders, emphasizing how autism spectrum disorder, ADHD, and other neurodivergent traits can influence addiction risk, clinical presentation, and treatment engagement.
What This Includes
• Core concepts in neurodiversity, including autism spectrum disorder and ADHD• The relationship between neurodivergent conditions and risk for substance use disorders• Shared neurobiologic mechanisms and common co-occurring psychiatric conditions• Clinical presentations of substance use disorders in neurodivergent individuals• Patterns of substance use influenced by factors such as social anxiety, sensory processing, and adaptive coping strategies• Adapted approaches to screening, treatment planning, and care delivery• Strategies to improve engagement and outcomes through individualized, patient-centered care
What to Expect
• Live, faculty-led instruction delivered in an interactive online format• Discussion of the unique challenges and strengths of neurodivergent individuals in addiction treatment settings• Structured content aligned with the ACAAM National Addiction Medicine Didactic Curriculum and ABPM content areas• Case-based examples illustrating assessment and treatment considerations• Practical guidance for providing accessible, individualized care to neurodivergent patients with substance use disorders
Eleasa Sokolski, MD
Dr. Sokolski is an addiction medicine physician specializing in the treatment of substance use and co‑occurring psychiatric disorders. She is board certified in Internal Medicine and Psychiatry.
Her work focuses on integrated care, medical education, and the application of psychotherapy in clinical settings, with an emphasis on patient‑centered approaches to recovery.
To support a meaningful learning experience and recognize your participation: